# Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study

> **NCT02057211** · PHASE2 · TERMINATED · sponsor: **Uppsala University Hospital** · enrollment: 10 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** autologous mesenchymal stem cell transplantation
- **PROCEDURE:** sham transplantation of mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02057211
- **Lead sponsor:** Uppsala University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Changed regulations of culture procedure
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057211, "Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02057211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*